CAPA Management

Overview

Corrective and Preventive Action (CAPA) is a critical element of an effective Quality Management System. CAPA should do more than close an observation — it should address the true root cause, reduce recurrence, and improve overall system performance.

Mediature GxP Solutions Pvt. Ltd. (MGS) supports pharmaceutical, biopharmaceutical, API, medical-device, laboratory, clinical, pharmacovigilance, and other regulated organizations with CAPA development, review, implementation, effectiveness assessment, and system improvement.

Our approach focuses on linking CAPA to evidence-based investigations, risk significance, clear ownership, realistic timelines, and measurable effectiveness.

Our CAPA Services

CAPA System Development

Development or strengthening of CAPA procedures, workflows, responsibilities, escalation mechanisms, and governance controls.

CAPA Review

Independent review of proposed CAPA for adequacy, root-cause linkage, clarity, feasibility, and regulatory relevance.

CAPA Development Support

Support for defining corrective and preventive actions based on confirmed root causes, contributing factors, and risk assessment.

CAPA Prioritization

Risk-based prioritization of CAPA according to potential impact on product quality, patient safety, data integrity, compliance, and operations.

CAPA Implementation Support

Assistance with action planning, responsibility assignment, documentation updates, training, system changes, and implementation tracking.

CAPA Effectiveness Checks

Development and review of effectiveness criteria to confirm whether implemented actions have successfully addressed the original issue.

CAPA Trending

Assessment of recurring CAPA themes, delayed actions, ineffective closures, repeated findings, and systemic weaknesses.

CAPA Backlog Reduction

Structured review and prioritization of overdue, aging, or high-volume CAPA backlogs to support timely and sustainable closure.

CAPA Sources We Support

CAPA may arise from:

• Deviations
• OOS/OOT investigations
• Internal audits
• Regulatory inspections
• Customer audits
• Supplier audits
• Complaints
• Recalls
• Data-integrity events
• Validation failures
• Equipment or utility issues
• Environmental monitoring events
• Quality risk assessments
• Management review
• Trend analysis
• Pharmacovigilance findings
• Computerized-system incidents

Key CAPA Focus Areas

MGS can support assessment of:

• Root-cause linkage
• Corrective versus preventive actions
• Action ownership
• Risk classification
• Due dates and timelines
• Interim controls
• Documentation changes
• Training requirements
• Process improvements
• System changes
• Validation impact
• Change-control requirements
• Effectiveness criteria
• Closure justification
• CAPA aging
• Recurring issues
• Trend analysis
• Management oversight

Our CAPA Approach

• Confirm the Root Cause

Review investigation evidence to ensure the CAPA is based on a scientifically and logically supported root cause.

• Define the Action

Develop actions that directly address the identified cause rather than only treating the immediate symptom.

• Assess Risk

Evaluate the potential impact of the issue and prioritize CAPA according to risk and regulatory significance.

• Implement

Assign responsibilities, define timelines, update procedures or systems, provide training, and execute required improvements.

• Verify Effectiveness

Use measurable and appropriate criteria to confirm that the CAPA has reduced or eliminated the risk of recurrence.

• Monitor & Trend

Review CAPA performance, recurring issues, delays, and effectiveness trends to identify broader system weaknesses.

CAPA Deliverables

Depending on the agreed scope, MGS can provide:

• CAPA system gap assessment
• CAPA procedure development or revision
• CAPA review
• Root-cause linkage assessment
• Corrective and preventive action recommendations
• CAPA prioritization framework
• CAPA tracker
• Effectiveness-check strategy
• CAPA trend analysis
• Backlog-reduction plan
• CAPA governance framework
• Training and coaching support

Why Choose MGS for CAPA Management

Root-Cause Focus

CAPA recommendations are developed around the actual underlying cause rather than superficial symptoms.

Risk-Based Prioritization

Actions are prioritized according to their potential impact on product quality, patient safety, data integrity, compliance, and operations.

Practical Implementation

MGS focuses on realistic actions that can be implemented and sustained within the client’s operating environment.

Cross-Functional Expertise

Our team can support CAPA involving quality, manufacturing, laboratory, engineering, validation, computerized systems, regulatory affairs, and pharmacovigilance.

Effectiveness-Oriented Approach

CAPA closure is not treated as the endpoint. We focus on whether the action has actually reduced recurrence and strengthened the system.

System Improvement

MGS can help clients identify recurring CAPA themes and broader quality-system weaknesses that require systemic improvement.

Who We Support

MGS can provide CAPA management support for:

• Pharmaceutical manufacturers
• API manufacturers
• Biopharmaceutical organizations
• Medical-device companies
• Laboratories
• Contract manufacturers
• CROs
• Pharmacovigilance organizations
• Warehouses and distribution operations
• Other regulated life-sciences organizations